Although we observed a decline but a non-statistical significance of the Trpc6 mRNA levels in both human AD and in 7PA2-treated neurons by RT-qPCRs, our preliminary results presented in Figure S5 suggest protein degradation is primarily responsible for the TRPC6 downregulation by AβOs. The gene discussed is TRPC6; the disease is Alzheimer disease.